HCC with portal vein tumor thrombosis: how to manage? Naoki Kawagishi Editorial 19 September 2020 Pages: 609 - 611
Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis Alexander J. KovalicSanjaya K. SatapathyPaul J. Thuluvath Review Article 28 July 2020 Pages: 612 - 620
Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis Yanyan WuHongyu LiXingshun Qi Review Article 24 July 2020 Pages: 621 - 637
Novel systemic therapy for hepatocellular carcinoma Yawen DongTsung-Hao LiuChiun Hsu Review Article 13 July 2020 Pages: 638 - 651
The role of neutrophils in innate immunity-driven nonalcoholic steatohepatitis: lessons learned and future promise Lihong WuXiang GaoJiao Guo Review Article 02 September 2020 Pages: 652 - 666
Interleukin-22 in alcoholic hepatitis and beyond Xiaogang XiangSeonghwan HwangBin Gao Review Article 05 September 2020 Pages: 667 - 676
Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders Saul J. KarpenDeirdre KellyPhilip Stein Review Article 11 July 2020 Pages: 677 - 689
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study) Shiv Kumar SarinAshok ChoudhuryAPASL COVID Task Force, APASL COVID Liver Injury Spectrum Study (APCOLIS Study-NCT 04345640) Original Article 04 July 2020 Pages: 690 - 700
Effect of COVID-19 on patients with compensated chronic liver diseases Dong JiDawei ZhangGeorge Lau Original Article 30 July 2020 Pages: 701 - 710
Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis Praveen Kumar-MShubhra MishraVishal Sharma Original Article 04 July 2020 Pages: 711 - 722
Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China Ming WangWeiming YanQin Ning Original Article Open access 07 October 2020 Pages: 723 - 732
Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury Ping LeiLan ZhangYuhu Song Original Article 04 September 2020 Pages: 733 - 742
Hepatitis B virus infection and diabetes mellitus: the Kailuan prospective cohort study in China Shaoyuan LeiShuohua ChenLi Wang Original Article 03 September 2020 Pages: 743 - 753
Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study Zhen-Hua ChenXiu-Ping ZhangShu-Qun Cheng Original Article 06 April 2020 Pages: 754 - 764
Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis Quan RaoMin LiZhongTao Zhang Original Article 22 June 2020 Pages: 765 - 775
Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib Yeonjung HaMohamed A. Mohamed AliKang Mo Kim Original Article 01 August 2020 Pages: 776 - 787
Stereotactic body radiotherapy versus hepatic resection for hepatocellular carcinoma (≤ 5 cm): a propensity score analysis Jing SunQuan WangXue-Zhang Duan Original Article 04 September 2020 Pages: 788 - 797
Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease Jung Nam AnSae Kyung JooWon Kim Original Article 17 June 2020 Pages: 798 - 807
Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease Chao CenWenpu WangShusen Zheng Original Article 22 June 2020 Pages: 808 - 816
Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study Jorge Luis PooAldo TorreLinda E. Muñoz-Espinosa Original Article Open access 19 August 2020 Pages: 817 - 827
Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction Xuequn ZhangYiming LinHang Zeng Original Article Open access 30 June 2020 Pages: 828 - 841
Maternal–fetal outcome in pregnancies complicated with non-cirrhotic portal hypertension: experience from a Tertiary Centre in South India Anish KeepanasserilAvantika GuptaDilip Kumar Maurya Original Article 25 June 2020 Pages: 842 - 849
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients Giovanni MarascoElton DajtiAntonio Colecchia Original Article 15 June 2020 Pages: 850 - 857
Functionality of beta-adrenergic receptors in patients with cirrhosis treated chronically with non-selective beta-blockers Susana AlmenaraBeatriz LozanoPedro Zapater Original Article 03 September 2020 Pages: 858 - 868
Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation Adil BaskiranSami AkbulutSezai Yilmaz Original Article 07 September 2020 Pages: 869 - 880
Liver injury in remdesivir-treated COVID-19 patients Rosa ZampinoFerruccio MeleEmanuele Durante-Mangoni Letter to the Editor 28 July 2020 Pages: 881 - 883
Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis Josephine A. GraceStephen CaseyPeter W. Angus Letter to the Editor 04 September 2020 Pages: 884 - 885
Is tenofovir more effective than entecavir to prevent hepatocellular carcinoma? The controversy goes on Cheng-Hao TsengMindie H. NguyenYao-Chun Hsu Letter to the Editor 13 August 2020 Pages: 886 - 887
